0001553878-15-000022.txt : 20150505
0001553878-15-000022.hdr.sgml : 20150505
20150505175757
ACCESSION NUMBER: 0001553878-15-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150501
FILED AS OF DATE: 20150505
DATE AS OF CHANGE: 20150505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vaishnaw Akshay
CENTRAL INDEX KEY: 0001458494
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 15834397
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-05-01
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001458494
Vaishnaw Akshay
C/O ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET
CAMBRIDGE
MA
02142
0
1
0
0
EVP, R&D, CMO
Common Stock
103
I
By Managed Account
Stock Option (Right to Buy)
96.45
2015-05-01
4
A
0
35125
0
A
2024-12-17
Common Stock
35125
35125
D
The reporting person owns 103 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
On December 17, 2014, the Compensation Committee of the Company approved the grant of stock options, at an exercise price of $96.45 per share, to members of its management team, including the Reporting Person. These stock option grants were approved subject to and contingent upon approval by the stockholders of the Company at its 2015 annual meeting of the Amended and Restated 2009 Stock Incentive Plan, to, among other things, increase the shares authorized for issuance thereunder. On May 1, 2015, the stockholders of the Company approved the Amended and Restated 2009 Stock Incentive Plan.
The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
/s/ Michael P. Mason, Attorney-in-Fact for: Akshay Vaishnaw
2015-05-05